Eszter Lázár-Molnár

Medical Director: Immunology
Associate Professor (Clinical), University of Utah School of Medicine

Education

• Doctorate Degree—Cell and Immune Biology, Semmelweis University
• Fellowship—Albert Einstein College of Medicine
• Fellowship—Research, Cancer Research Institute
• Fellowship—Clinical Immunology, University of Utah

Certification/Affiliations

• American Board of Medical Laboratory Immunology
• American Board of Histocompatibility and Immunogenetics

Research Interests

• Immunotherapy, immunogenicity testing for biologics
• Transplantation testing, HLA, and disease associations
• Immune monitoring, CyTof

Awards

• Doctorate Research Award, Semmelweis University, 2001
• Belfer Prize for outstanding postdoctoral research, Albert Einstein College of Medicine, 2008
• Junior Faculty Travel Award, AAI 97^th Annual Meeting, 2010
• Travel Award, AMLI, 27^th Annual Meeting, 2014
• Travel Award, CIS 2015 School in Primary Immunodeficiency Diseases
• Best Case Study Presentation – BMT, ASHI, 42^nd Annual Meeting, 2016

Recent Publications

• Ravkov EV, et al. Evaluation of mass cytometry in the clinical laboratory. Cytometry B Clin Cytom. 2019; 96(4):266–74.
• Lázár-Molnár E, Delgado JC. Implications of monoclonal antibody therapeutics use for clinical laboratory testing. Clin Chem. 2019;65(3):393–405.
• Pavlov IY, et al. Inductively coupled plasma mass spectrometry assay for quantification of free infliximab in serum. J Immunol Methods. 2019;470:33–9.
• Lázár-Molnár E, Snyder M. The role of human leukocyte antigen in celiac disease diagnostics. Clin Lab Med.2018;38(4):655–68.
• Profaizer T, et al. HLA genotyping using the Illumina HLA TruSight next-generation sequencing kits: a comparison. Int J Immunogenet. 2017;44(4):164–8.
• Lázár-Molnár E, et al. Structure-guided development of a high-affinity human Programmed Cell Death-1: implications for tumor immunotherapy. 2017;17:30–44.